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Figure 1. Lysosome fusion. 
Lysosomes fuse with late endosomes to form endolysosomes, which are major sites of acid hy-
drolase activity and the digestion of endocytosed cargo. Equivalent fusions of lysosomes with 
phagosomes or autophagosomes can also occur (not shown in detail).  Lysosomes can be re-
formed from endolysosomes and autolysosomes via poorly understood fi ssion and maturation 
processes. Traffi c routes from the trans-Golgi network (TGN) deliver newly synthesized proteins 
to endosomes and lysosomes.Lysosomes
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What are lysosomes? Lysosomes are 
membrane-bound organelles that are 
found in animal cells and contain over 
50 different acid hydrolases. These 
dynamic organelles function at the 
end of the endocytic, autophagic and 
phagocytic pathways, with lysosomal 
acid hydrolases being used to break 
down a wide variety of macromolecules 
delivered through these pathways. 
Lysosomes may constitute up to 5% 
of the intracellular volume and are of 
heterogeneous size and morphology, 
often containing electron-dense 
deposits and membrane whorls. The 
lack of mannose-6-phosphate receptors 
(MPRs) is often used to distinguish 
them from other late endocytic 
compartments. 
When were they discovered? 
Lysosomes were discovered by 
Christian de Duve over 60 years ago 
when he showed that the measured 
activity of acid hydrolases greatly 
increased following exposure of 
subcellular fractions to ‘ageing’ 
in the refrigerator, hypotonic 
media, detergents, or other insults 
to membrane integrity. Electron 
microscopy and the use of acid 
phosphatase cytochemistry later 
established the morphological identity 
of lysosomes.
How do they function in membrane 
traffi cking pathways? Lysosomes 
interact with late endosomes (also 
known as multivesicular bodies or 
MVBs) by direct fusion or ‘kiss-and-
run’ events. In ‘kiss-and-run’ events, 
transient contact of the organelles 
occurs, followed by exchange of 
content and then dissociation of 
the organelles. Current models of 
lysosome function suggest that the 
endolysosomes formed as a result 
of such interactions are the main 
site of action of the acid hydrolases 
(and effectively act as intracellular 
‘stomachs’ for macromolecule 
digestion), with terminal lysosomes 
being more akin to quiescent storage 
Quick guide organelles for these enzymes (Figure 1). 
Similarly, fusion of lysosomes with 
autophagosomes results in the 
formation of autolysosomes, and 
fusion with phagosomes generates 
phagolysosomes. 
Genetic screens in yeast, in which the 
vacuole acts as a specialized lysosome, 
together with mammalian cell-free and 
cultured cell systems have enabled the 
identifi cation of much of the protein 
machinery that is involved in traffi cking 
to lysosomes. The ubiquitous SNARE 
(soluble N-ethylmaleimide-sensitive 
factor-attachment protein receptor) 
machinery for intracellular membrane 
fusion is used for lysosome fusions. 
There are differences in the SNARE 
proteins depending on the organelle 
membrane to which the lysosome 
is fusing. Prior to SNARE-mediated 
membrane fusion of lysosomes with 
late endosomes or autophagosomes, 
tethering of the organelles occurs. This 
requires both a small GTPase of the 
Rab family and the homotypic fusion 
and vacuole protein sorting (HOPS) 
complex, which was fi rst identifi ed in 
yeast.
How do lysosomes maintain an 
acidic lumen? The acid hydrolases 
in lysosomes require an acidic Current Biology 25, R301–R327, April 20, 2015 ©environment with a pH of less than 5 
for maximum activity. This is provided 
through the activity of the proton-
pumping V-ATPase found in the 
limiting membrane. Both unspecifi ed 
cation channels and the lysosomal 
Cl-/H+ antiporter ClC-7/Ostm1 are 
partially responsible for the necessary 
charge compensation. Such cation 
channels and ClC-7/Ostm1 also play 
a role in lysosomal ion homeostasis 
and modulate the voltage across the 
lysosomal membrane.
Is their limiting membrane 
specialized? The limiting membrane 
of the lysosome contains more than a 
hundred proteins, of which the most 
abundant are the type 1 transmembrane 
proteins LAMP-1 and LAMP-2 (for 
lysosomal-associated membrane 
protein 1 and 2) that together account 
for ~50% of lysosomal membrane 
protein content. An ~8 nm thick 
glycocalyx made up primarily of the 
oligosaccharide side chains on LAMP-1 
and LAMP-2 is thought to protect the 
limiting membrane from being damaged 
by the acid hydrolases. One isoform of 
LAMP-2, LAMP-2A, is able to transport 
about 30% of cytosolic proteins 
(those containing a KFERQ motif) into 
lysosomes for degradation, a process 2015 Elsevier Ltd All rights reserved R315
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In addition to the LAMPs, V-ATPase, 
ion transporters and channels, the 
lysosomal membrane contains 
transporters for the amino acid, sugar 
and lipid products of macromolecule 
digestion. Furthermore, the cytosolic 
surface is specialized, acting as a 
localization site for some signaling 
complexes, notably mammalian target of 
rapamycin complex 1 (mTORC1), which 
is recruited through an interaction with 
small GTPases of the Rag family. Rag 
GTPases are themselves recruited to 
the lysosome surface by the ragulator 
complex, which interacts with V-ATPase. 
How are lysosomes made? 
Biosynthesis of lysosomes entails the 
coordinated transcription of genes 
encoding lysosomal proteins. These 
genes have a CLEAR (coordinated 
lysosomal expression and regulation) 
element in their promoter region that 
can bind to transcription factor EB 
(TFEB), which mediates upregulation 
of transcription under conditions such 
as starvation or lysosome dysfunction. 
Most newly synthesized acid hydrolases 
are tagged with mannose-6-phosphate 
and traffi c from the trans-Golgi network 
(TGN) to endosomes/lysosomes 
via attachment to a MPR. The acid 
hydrolases dissociate from the MPRs 
as a result of the acidic endosomal 
pH, allowing the receptors to recycle 
to the TGN. MPR-independent routes 
for targeting lysosomal enzymes have 
been described, such as the delivery 
of -glucocerebrosidase using the 
lysosomal membrane protein LIMP-2 as 
the traffi cking receptor. 
Many lysosomal membrane proteins 
have sequence motifs in their cytosolic 
tails that target them to lysosomes. 
Such tails are often short, containing 
either GYXXØ (where X is any amino 
acid and Ø is a bulky hydrophobic 
amino acid) or [DE]XXXL[LI] motifs 
that can also function as endocytic 
signals. The clathrin/adaptor machinery 
is required to traffi c both MPRs and 
lysosomal membrane proteins, with 
the adaptor AP-3 having a particular 
role in traffi cking lysosomal membrane 
proteins. Specialized carrier vesicles 
delivering some lysosomal membrane 
proteins from the TGN have also been 
identifi ed.
Quiescent terminal lysosomes can 
be re-formed from endolysosomes or R316 Current Biology 25, R301–R327, April 2autolysosomes through maturation 
processes that include the removal or 
recycling of endosomal proteins, such 
as SNAREs and MPRs, the formation 
of tubular protolysosomes, and 
content condensation. Some terminal 
lysosomes may accumulate indigestible 
macromolecules and become residual 
bodies that can no longer contribute to 
the dynamic pathway of endolysosome 
formation or to re-formation of 
quiescent terminal lysosomes.
Are lysosomes simply cell stomachs 
or do they have other functions? 
In many cell types lysosomes are 
capable of undergoing fusion with 
the plasma membrane, a process 
implicated in plasma membrane repair 
and defence against some parasites. 
Some specialized cell types contain 
lysosome-related organelles (LROs) 
or secretory lysosomes that contain 
specialized proteins destined for 
secretion in addition to acid hydrolases. 
The cytosolic surface of the lysosome 
membrane is now recognized as 
a major site of action of signalling 
complexes that regulate cellular 
metabolism. mTOR, which integrates 
signals arising from nutrients, energy 
and growth factors, has a diffuse 
localization under starvation conditions, 
but, as part of the mTORC1 complex, 
is recruited to the lysosome surface in 
the presence of amino acids. mTOR is 
involved in the lysosomal recruitment 
and phosphorylation of TFEB, which 
is then dephosphorylated following 
starvation and rapidly translocated to 
the nucleus where it acts as a master 
regulator of genes required for lysosome 
biogenesis, lysosome exocytosis, 
macroautophagy and lipophagy. In 
the nematode Caenorhabditis elegans 
lipid breakdown in lysosomes has 
been linked to the promotion of 
longevity. Increased life span is the 
result of lysosomal production of the 
bioactive lipid oleoylethanolamide, 
which is translocated into the nucleus 
by a chaperone protein and affects the 
transcription of genes that regulate 
longevity.
Are lysosomes involved in disease? 
Lysosomal storage diseases (LSDs) 
occur with an incidence of about 
1 in 5,000 live births and comprise 
over 50 genetically distinct disorders. 
In these diseases, defi ciencies 0, 2015 ©2015 Elsevier Ltd All rights reservedin lysosomal enzymes or in non-
enzymatic lysosomal proteins lead to 
abnormal storage of macromolecular 
substrates. The involvement of the 
central nervous system is common 
in LSDs, and neurodegeneration can 
occur in multiple brain regions. Current 
therapeutic approaches include enzyme 
replacement and substrate reduction, 
but there are major challenges in 
crossing the blood–brain barrier to treat 
diseases of the central nervous system. 
Lysosomal diseases extend beyond 
the LSDs and include, for example, 
some hereditary spastic paraplegias, 
where lysosome re-formation from 
autolysosomes is impaired. Lysosome 
and macroautophagy dysfunction 
also contributes to common 
neurodegenerative disorders, such 
as Parkinson’s, Alzheimer’s and 
Huntington’s diseases. Some infectious 
agents, including Ebola virus, need to 
access lysosomes to cause infection. 
Several diseases arising from defects 
in the biogenesis or function of LROs 
are also known. Examples include 
several human immunodefi ciencies, 
namely familial haemophagocytic 
lymphohistiocytosis, Griscelli syndrome, 
Hermansky-Pudlak syndrome and 
Chédiak-Higashi syndrome, in which 
there are abnormalities in biosynthesis 
and function of LROs in cytotoxic 
T lymphocytes.  In the syndromes 
mentioned there are also abnormalities 
in LROs in other cell types.
Where can I fi nd out more?
de Duve, C. (2005). The lysosome turns fi fty. Nat. Cell 
Biol. 7, 847–849.
Han, S. and Brunet, A. (2015). Lysosomal lipid 
lengthens life span. Science 347, 32–33.
Huotari, J. and Helenius, A. (2011). Endosome 
maturation. EMBO J. 30, 3481–3500. 
Luzio, J.P., Hackmann, Y., Dieckmann, N.M. and 
Griffi ths, G.M. (2014). The biogenesis of 
lysosomes and lysosome related organelles. 
Cold Spring Harb. Perspect. Biol. 6, a016840. 
Platt, F.M., Boland, B. and van der Spoel, A.C. (2012). 
The cell biology of disease: lysosomal storage 
disorders: the cellular impact of lysosomal 
dysfunction. J. Cell Biol. 199, 723–734. 
Settembre, C., Fraldi, A., Medina, D.L. and 
Ballabio, A. (2013). Signals from the lysosome: 
a control centre for cellular clearance and 
energy metabolism. Nat. Rev. Mol. Cell Biol. 14, 
283–296. 
Xu, H. and Ren, D. (2015). Lysosomal physiology. 
Annu. Rev. Physiol. 77, 57–80.
Cambridge Institute for Medical Research and 
Department of Clinical Biochemistry, University 
of Cambridge School of Clinical Medicine, 
Wellcome Trust/MRC Building, Cambridge 
Biomedical Campus, Hills Road, Cambridge 
CB2 0XY, UK.
*E-mail: jpl10@cam.ac.uk
